SAN DIEGO, May 11, 2012 /PRNewswire/ -- Cadence
Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company
focused on acquiring, in-licensing, developing and commercializing
proprietary product candidates principally for use in the hospital
setting, announced today that the company's President and CEO
Ted Schroeder will present the
company's corporate overview on Tuesday, May
15, 2012 at 2:00pm Pacific
Time (5:00pm Eastern Time)
during the JMP Securities 11th Annual Research Conference at the
Ritz-Carlton Hotel in San
Francisco.
The presentation will be simultaneously webcast and can be
accessed on Cadence Pharmaceuticals' website at
www.cadencepharm.com in the Investor Relations section. A
replay of the webcast will be available approximately three hours
following the live webcast and will be archived for 30 days.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused
on acquiring, in-licensing, developing and commercializing
proprietary products principally for use in the hospital
setting. The current version of Cadence Pharmaceuticals'
corporate overview may be viewed on the "Investors" page of
www.cadencepharm.com, under "Events and Presentations."
Contacts:
|
William R.
LaRue
SVP,
CFO
Cadence
Pharmaceuticals, Inc.
858-436-1400
|
SOURCE Cadence Pharmaceuticals, Inc.